FGF21 mutants and uses thereof

Details for Australian Patent Application No. 2009256232 (hide)

Owner Amgen Inc.

Inventors Hamburger, Agnes Eva; Michaels, Mark Leo; Li, Yue-Sheng; Xu, Jing; Ellison, Murielle Marie; Hecht, Randy Ira; Sun, Jeonghoon; Belouski, Edward John

Agent Shelston IP

Pub. Number AU-B-2009256232

PCT Pub. Number WO2009/149171

Priority 61/058,919 04.06.08 US; 61/164,364 27.03.09 US; 61/175,736 05.05.09 US; 61/058,861 04.06.08 US

Filing date 3 June 2009

Wipo publication date 10 December 2009

Acceptance publication date 22 December 2011

International Classifications

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/149171 Priority application(s): WO2009/149171

22 December 2011 Application Accepted

  Published as AU-B-2009256232

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256236-Handheld radiation delivery system for advancing a radiation source wire

2009256222-Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling